Can the mediterranean diet survive chemo? new study investigates

NCT ID NCT06058312

Completed Knowledge-focused Sponsor: Centre Antoine Lacassagne Source: ClinicalTrials.gov ↗

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looked at how cancer treatment changes patients' ability to stick with a Mediterranean diet. Researchers followed 116 patients starting chemotherapy or immunotherapy, checking their diet adherence and sensory changes (taste and smell) at the start and after 9 weeks. The goal is to understand why patients eat differently during treatment, which could lead to better nutritional support and less malnutrition.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this research could help design better dietary support for cancer patients, potentially reducing malnutrition during treatment.
What could go wrong: This is a small, exploratory study with no direct treatment. Results may not apply to all cancer types or treatments, and dietary changes are hard to measure accurately.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for NEOPLASMS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

NEOPLASMS

Contacts and locations

Locations

Centre Antoine lacassagne

Nice, 06000, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.